Bonesupport Holding AB
STO:BONEX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
162.5
370.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bonesupport Holding AB
Bonesupport Holding AB
Capital Expenditures
Bonesupport Holding AB
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bonesupport Holding AB
STO:BONEX
|
Capital Expenditures
-kr8.4m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Capital Expenditures
-kr48.6m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Capital Expenditures
-kr156m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Probi AB
STO:PROB
|
Capital Expenditures
-kr57.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-16%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Capital Expenditures
-kr3.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-42%
|
|
|
BioArctic AB
STO:BIOA B
|
Capital Expenditures
-kr7.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Bonesupport Holding AB
Glance View
The company is headquartered in Lund, Skane and currently employs 92 full-time employees. The company went IPO on 2017-06-21.
See Also
What is Bonesupport Holding AB's Capital Expenditures?
Capital Expenditures
-8.4m
SEK
Based on the financial report for Sep 30, 2024, Bonesupport Holding AB's Capital Expenditures amounts to -8.4m SEK.
What is Bonesupport Holding AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-25%
Over the last year, the Capital Expenditures growth was -146%. The average annual Capital Expenditures growth rates for Bonesupport Holding AB have been -66% over the past three years , -25% over the past five years .
You don't have any saved screeners yet
